Most Read Articles
Roshini Claire Anthony, 4 days ago

The combined use of piperacillin and tazobactam does not appear to be a suitable alternative to meropenem for patients with bloodstream infections caused by ceftriaxone-resistant Escherichia coli (E. coli) or Klebsiella pneumoniae (K. pneumoniae), according to results of the MERINO* trial.

Tristan Manalac, 19 May 2018
Taking oral antibiotics appears to increase the risk of nephrolithiasis, according to a recent study. Moreover, the risk seems to be compounded for individuals with recent antibiotic exposure and those who were exposed at a younger age.
2 days ago
Patients with inflammatory bowel disease are at increased risk of developing acute myocardial infarction (AMI) or heart failure, although the prevalence of traditional risk factors for such cardiovascular disorders appears to be low, as reported in a recent study.
3 days ago
Early renin-angiotensin-aldosterone system (RAAS) blockade with renin-angiotensin system inhibitors (RASI) leads to better short- and long-term renal outcomes in systemic lupus erythematosus (SLE) patients with antiphospholipid-associated nephropathy (aPLN), according to a study, adding that this renal protective effect is independent of RASI’s antihypertensive and antiproteinuric effects.

Irradiation stents confer better survival, stent patency than uncovered SEMS

15 May 2018

Insertion of an irradiation stent leads to longer survival and better patency than uncovered self-expandable metallic stents (SEMS) in patients with unresectable malignant biliary obstruction (MBO), a recent multicentre trial has found.

Stent restenosis was less frequent in patients who received irradiation stents than in those who received uncovered SEMS (21 percent vs 34 percent). Irradiation stents were associated with significantly lower rates of restenosis (cause-specific hazard ratio, 0.479; 95 percent CI, 0.312–0.737).

The rate of stent restenosis was also lower in the irradiation stent vs uncovered SEMS group at 90 days (9 percent vs 15 percent), 180 days (16 percent vs 27 percent) and 360 days (21 percent vs 33 percent; p=0.01).

Moreover, while the median patency time in the uncovered SEMS group was 294 days, the same value could not be determined for the irradiation stents group due to the low rate of restenosis.

Overall survival was likewise better in the irradiation stent group, whose median survival of 202 days was significantly longer than the 140 days in the uncovered SEMS group (p=0.002).

“For patients with unresectable MBO, placement of an SEMS is a recommended palliative modality to relieve pruritus, cholangitis, pain and jaundice. However, restenosis is a main pitfall after stent placement,” said researchers.

“Data from this first multicentre randomized controlled trial showed that insertion of an irradiation stent provided longer patency and better survival compared with a conventional metal stent,” they added.

For the study, researchers randomized 328 participants to receive either irradiation stents (n=164; median age 65 years; 62.8 percent male) or uncovered SEMS (n=164; median age 64 years; 66.5 percent male). Cox regression and Fine-Gray analyses were performed to evaluate the effect of the different interventions on restenosis.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, 4 days ago

The combined use of piperacillin and tazobactam does not appear to be a suitable alternative to meropenem for patients with bloodstream infections caused by ceftriaxone-resistant Escherichia coli (E. coli) or Klebsiella pneumoniae (K. pneumoniae), according to results of the MERINO* trial.

Tristan Manalac, 19 May 2018
Taking oral antibiotics appears to increase the risk of nephrolithiasis, according to a recent study. Moreover, the risk seems to be compounded for individuals with recent antibiotic exposure and those who were exposed at a younger age.
2 days ago
Patients with inflammatory bowel disease are at increased risk of developing acute myocardial infarction (AMI) or heart failure, although the prevalence of traditional risk factors for such cardiovascular disorders appears to be low, as reported in a recent study.
3 days ago
Early renin-angiotensin-aldosterone system (RAAS) blockade with renin-angiotensin system inhibitors (RASI) leads to better short- and long-term renal outcomes in systemic lupus erythematosus (SLE) patients with antiphospholipid-associated nephropathy (aPLN), according to a study, adding that this renal protective effect is independent of RASI’s antihypertensive and antiproteinuric effects.